T1	OtherOutcome 12 44	All AEs, serious and non-serious
T2	PrimaryOutcome 228 367	relative change (%) from baseline (day 1 prior to study drug administration at Â± 1h of randomization) in PaO2/FiO2 ratio in supine position
T3	TimeFrame 368 379	at day five
R1	MeasuredAt Arg1:T2 Arg2:T3	
